Medical Science

  • Home

Volume 25, Issue 118, December 2021

A malignant transformation of benign phyllode tumor of breast and its management: A case report from India

Meenal Rajput1♦, Md. Jawed Akhter2, Lamture YR3, Gaurav Jagtap4

1Junior Resident Medical Officer, Department of Surgery, Shri Shankaracharya Institute of Medical Science, Junwani, Durg-490020, Chhattisgarh, India
2HOD & Professor, Department of Surgery, Shri Shankaracharya Institute of Medical Science, Junwani, Durg-490020, Chhattisgarh, India
3Professor, Department of Surgery, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha, Maharashtra, India
4Junior Resident, Department of Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed to be University), Sawangi (Meghe), Wardha-442001, Maharashtra, India

♦Corresponding author
Junior Resident Medical Officer, Department of Surgery, Shri Shankaracharya Institute of Medical Science, Junwani, Durg-490020, Chhattisgarh, India;

ABSTRACT

Phyllode tumor (PT) of a breast is mostly benign, it shows a very rare transformation into malignant PT. Globally, less than a percentage of cases get reported for breast tumors. We reported the case of a recurring tumor in a woman of age 48 years with a lump on her left breast. She has gone through a resection twice. Firstly, post excision H/P reported fibroadenoma. Secondly, the excision of benign PT transformed to malignant phyllode within 3 months of resection. The results from images of CT scan, intraoperative, and pathological slides from the specimen of mastectomy have made us conclude that the malignant transition is caused by a mutation in residual tumor cells. Then, the total mastectomy with low axillary lymphadenectomy was done. Further, the patient was advised for adjuvant chemotherapy within 2 weeks and radiation therapy to the chest within 4 months of surgery. The patient is also advised to attend the follow-up appointments with the oncologist monthly for a minimum of 2 years after completion of adjuvant chemoradiotherapy

Keywords: Breast, Benign phyllode tumor, Recurrence, Malignant transformation, malignant phyllode tumor

Medical Science, 2021, 25(118), 3231-3236
PDF

© Discovery Scientific Society.  All Rights Reserved
Kanyakumari District, Tamilnadu, India